Related Experiment Video
Updated: Jul 3, 2026

Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
Published on: November 25, 2017
Alpha-mannosidosis
1Department of Gastroenterology, University Hospital of North Norway, NO-9038, Norway. dag.malm@unn.no
Insights
Alpha-mannosidosis is a rare inherited disorder causing immune deficiency, intellectual disability, and skeletal issues due to alpha-mannosidase deficiency. Early diagnosis and proactive management are crucial for improving patient outcomes and quality of life.
Area of Science:
- Genetics and Genetic Disorders
- Biochemistry
- Lysosomal Storage Diseases
Background:
- Alpha-mannosidosis is a rare autosomal recessive inherited lysosomal storage disorder.
- It is caused by deficiency of the enzyme alpha-mannosidase, leading to accumulation of mannose-rich oligosaccharides.
- The condition presents with a wide spectrum of clinical manifestations, including immune deficiency, skeletal abnormalities, hearing impairment, and intellectual disability.
Purpose of the Study:
- To provide a comprehensive overview of Alpha-mannosidosis.
- To highlight the genetic basis, clinical features, diagnostic approaches, and management strategies.
- To emphasize the importance of early intervention and genetic counseling.
Main Methods:
- Literature review of existing studies and clinical data on Alpha-mannosidosis.
- Analysis of diagnostic criteria, including biochemical assays and genetic testing.
- Review of current management protocols and long-term prognosis.
Main Results:
- Alpha-mannosidosis affects approximately 1 in 500,000 live births, with significant clinical variability.
- Key features include recurrent infections, dysostosis multiplex, sensorineural hearing loss, and progressive cognitive and motor decline.
- Diagnosis relies on measuring alpha-mannosidase activity and genetic confirmation via mutations in the MAN2B1 gene.
Conclusions:
- Alpha-mannosidosis is a severe lysosomal storage disorder with a poor long-term prognosis, often leading to wheelchair dependency and limited social independence.
- Proactive management, including infection treatment, supportive therapies, and early educational intervention, is essential.
- Genetic counseling and antenatal diagnosis are vital for affected families.
Abstract:
Alpha-mannosidosis is an inherited lysosomal storage disorder characterized by immune deficiency, facial and skeletal abnormalities, hearing impairment, and intellectual disability. It occurs in approximately 1 of 500,000 live births. The children are often born apparently normal, and their condition worsens progressively. Some children are born with ankle equinus or develop hydrocephalus in the first year of life. Main features are immune deficiency (manifested by recurrent infections, especially in the first decade of life), skeletal abnormalities (mild-to-moderate dysostosis multiplex, scoliosis and deformation of the sternum), hearing impairment (moderate-to-severe sensorineural hearing loss), gradual impairment of mental functions and speech, and often, periods of psychosis. Associated motor function disturbances include muscular weakness, joint abnormalities and ataxia. The facial trait include large head with prominent forehead, rounded eyebrows, flattened nasal bridge, macroglossia, widely spaced teeth, and prognathism. Slight strabismus is common. The clinical variability is significant, representing a continuum in severity. The disorder is caused by lysosomal alpha-mannosidase deficiency. Alpha-mannosidosis is inherited in an autosomal recessive fashion and is caused by mutations in the MAN2B1 gene located on chromosome 19 (19 p13.2-q12). Diagnosis is made by measuring acid alpha-mannosidase activity in leukocytes or other nucleated cells and can be confirmed by genetic testing. Elevated urinary secretion of mannose-rich oligosaccharides is suggestive, but not diagnostic. Differential diagnoses are mainly the other lysosomal storage diseases like the mucopolysaccharidoses. Genetic counseling should be given to explain the nature of the disease and to detect carriers. Antenatal diagnosis is possible, based on both biochemical and genetic methods. The management should be pro-active, preventing complications and treating manifestations. Infections must be treated frequently. Otolaryngological treatment of fluid in the middle ear is often required and use of hearing aids is invariably required. Early educational intervention for development of social skills is needed and physiotherapy is important to improve bodily function. Orthopedic surgery may be necessary. The long-term prognosis is poor. There is an insidiously slow progression of neuromuscular and skeletal deterioration over several decades, making most patients wheel-chair dependent. No patients manage to be completely socially independent. Many patients are over 50 years of age.
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Proteoglycans
Lysosomal Hydrolases
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Export of Misfolded Proteins out of the ER
